PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
11-Jun-2020 ICR and Cancer Research UK spinout company Monte Rosa Therapeutics launches with library of anti-cancer compounds Cancer Research UK
11-Jun-2020 Abbott Donates FreeStyle Libre Sensors for Hospitalised Patients with Diabetes in the UK During COVID-19 Pandemic Abbott
11-Jun-2020 RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib RedHill Biopharma
11-Jun-2020 Genmab and AbbVie Announce Broad Oncology Collaboration Genmab
11-Jun-2020 Orgenesis announces anti-viral “BioShield” program designed to potentially increase preparedness, rapidly address virus spread and protect against future outbreaks such as COVID-19 Orgenesis
11-Jun-2020 ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials ERT
11-Jun-2020 Ashvattha Therapeutics Subsidiary Orpheris Announces Completion of Phase 1 Study of OP-101 Subcutaneous Formulation Ashvattha Therapeutics
11-Jun-2020 Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases Dupixent
11-Jun-2020 Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing The European Investment Bank
11-Jun-2020 Biophytis Receives MHRA Approval to Initiate the COVA Clinical Trial in the UK with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure BIOPHYTIS
11-Jun-2020 Quell Therapeutics strengthens its Board with the appointments of Dr Dhaval Patel and Sir Robert Lechler and hires Dr Natalie Belmonte as SVP Research & Translation Quell Therapeutics
11-Jun-2020 Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020 Bone Therapeutics
11-Jun-2020 Zelluna Immunotherapy raises funds to fully focus on developing allogeneic “off-the-shelf” TCR based Natural Killer (TCR-NK) cell therapies About Zelluna Immunotherapy
11-Jun-2020 Alnylam Announces Publication of ENVISION Phase 3 Study Results for Givosiran in The New England Journal of Medicine Alnylam Pharmaceuticals, Inc.
10-Jun-2020 ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials ERT
08-Jun-2020 WORLD EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET RESEARCH REPORT 2025, COVID BUSINESS IMPACT INFORMATION COVERED The Holistic Reports
08-Jun-2020 Press Launch of hVIVO COVID Clear Test, the most accurate antibody test available to UK employers to help get people back to work hVIVO
08-Jun-2020 UCB Shares Breadth of Innovative New Data from Rheumatology Portfolio for EULAR 2020 E-Congress UCB
08-Jun-2020 AbbVie at EULAR - RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients AbbVie
08-Jun-2020 US FDA Grants Mexiletine Orphan Drug Designation Lupin